LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- At CES 2026, Tensor today announced the official open-source release of OpenTau ( ), a powerful AI training toolchain designed to accelerate the development of ...

By the close of trading, Applied Digital's stock price was up more than 8% after rising as much as 20% earlier in the day.

Lightweight Linux distributions get a bad rap for shipping with minimal reinstalled software. Besgnulinux, loaded with old-school charm, is the exception.

Applied Digital reported second-quarter revenue above Wall Street estimates on Wednesday, as the data center operator benefited from strong demand for its large-scale facilities for artificial ...

Perovskite solar cells (PSCs) have emerged as promising alternative for next generation photovoltaics due to their superior power conversion efficiencies (record currently at 34.9% for ...

A new year is coming, and with it some new food at M&S that is bound to prove popular with those taking weight loss jabs like ...

In February, the Government announced the Applied Doctorate Scheme (ADS) - a $20 million programme to help prepare PhD students for world-class careers in science, by building stronger connections ...

Applied Digital Corp (NASDAQ: APLD) shares are trending on Monday. Here’s a look at what you need to know. What To Know: Applied Digital has shifted its primary focus from hosting Bitcoin mining ...

Shares of Applied Materials Inc. were down Friday after the company delivered a slight earnings beat but flat guidance on Thursday. Despite declines in its key China business due to U.S. trade ...

We recently published 10 Stocks Delivering Explosive 18-190% Gains. Applied Optoelectronics Inc. (NASDAQ:AAOI) is one of the last week’s heavy gainers. Applied Optoelectronics jumped by 20.56 percent ...

Applied Digital boasts an exceptionally strong long-term demand visibility. The company is focused on rapidly expanding its data center capacity to meet surging demand. Applied Digital has also ...

Applied Therapeutic’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases NEW YORK, Dec. 11, 2025 ...